Evaluation of prognostic parameters of E-cadherin status in breast cancer treatment

Anna Brzozowska 1, Tomasz Sodolski 2, Dariusz Duma 3, Tomasz Mazurkiewicz 4, Maria Mazurkiewicz 4
1 - Department of Oncology, Medical University in Lublin, Poland
2 - Cardiology Department, Medical University in Lublin, Poland
3 - Department of Laboratory Diagnostic, Medical University in Lublin, Poland
4 - Orthopedics and Traumatology Department, Medical University in Lublin, Poland
Ann Agric Environ Med
2012; 19 (3):
ICID: 1010936
Article type: Original article
Introduction and objective. Breast cancer is one of the most frequent malignancies in women. Axillary lymph node involvement, tumour size, receptor status, and level of malignancy are the most significant prognostic factors in breast cancer, but insufficient to date. More factors are needed for establishing the prognosis and treatment in these patients. The aim of the presented study was evaluation of E- cadherin expression and its prognostic value among 89 specimens of breast cancer.
Materials and methods. 89 formalin-fixed and paraffin-embedded breast cancer specimens were studied for expression of E-cadherin detected by immunohistochemistry. During 10-year observation overall/OS/and disease-free survival/DFS/of patients were assessed.
Results. Average of OS and DFS were shorter among patients without expression of E-cadherin in comparison to survival time of patients with expression of E-cadherin.
The lack of E-cadherin expression was present more often among patients with distant metastasis. No essential changes were noticed in the level of E-cadherin depending on the size of the tumour, G, presence of metastasis into the lymph nodes, ER, PR and HER-2, hormonal condition and presence of cancerous tissues in lymphatic vessels and the infiltration of lymph nodes capsules.
Conclusions. E-cadherin may play an important role in the prognosis of breast cancer patients.
PMID 23020053 - click here to show this article in PubMed

Recommend this article to:


Related articles in IndexCopernicus™
     breast cancer [900 related records]
     Prognosis [7420 related records]
     E-cadherin [22 related records]


Related articles

 Prognostic value of interim 18F-PET/CT in pa...
 Objective: The aim of this study is to determine the prognostic value of interim 18F-FDG-PET/CT in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL).Methods: The data of 69 patients with newly diagnosed DLBCL treated with R-CH...
E Kobryń, K Kobryń,
Is there a rationale for aggressive breast cancer ...
Introduction. Breast cancer (BC) makes up nearly 26% of malignant tumours worldwide and is the leading cause of cancer-related deaths in European women. With approximately 18,000 new cases of BC diagnosed in Polish women annually, breast cance...
, ,
 BACKGROUND AND OBJECTIVES Peritonitis due to hollow viscous perforation is one of the most common surgical emergencies in surgical practice. This may be due to persistence of the various risk factors among population like H. pylori infection...